PM
PharmaCyte Biotech, Inc.
PMCB · NASDAQ
$0.44 -8.03% (-$0.04)
1M -19.20%
Market Cap $4.75M
P/E Ratio -
Div. Yield -
ROE 50.84%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.14x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 2,751.79%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 15.49%
ROE 50.84%
ROA 41.55%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 45.28x
Int. coverage N/A
Stability
37 /100
Moderate Beta 0.66x
EPS volatility 250.18%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PMCB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joshua N. Silverman
Employees
2
Headquarters
Las Vegas